World News

Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo...

Ogkologos - 10 Ιουνίου, 2025

Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC

Ogkologos - 6 Ιουνίου, 2025

FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma

Ogkologos - 6 Ιουνίου, 2025

ESMO Gynaecological Cancers Congress 2025, Vienna, Austria, 19-21 June

Ogkologos - 5 Ιουνίου, 2025

EMA Recommends Granting a Conditional Marketing Authorisation for Zanidatamab

Ogkologos - 5 Ιουνίου, 2025

Vepdegestrant Results in Longer PFS Than Fulvestrant in Previously Treated Patients...

Ogkologos - 4 Ιουνίου, 2025

Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and...

Ogkologos - 3 Ιουνίου, 2025

Similar Median OS Between Ripretinib versus Sunitinib in Patients with Advanced...

Ogkologos - 2 Ιουνίου, 2025

FDA Grants Accelerated Approval to the Combination of Avutometinib and Defactinib...

Ogkologos - 30 Μαΐου, 2025

EMA Adopts a Positive Opinion for Biosimilar Denosumab

Ogkologos - 28 Μαΐου, 2025

1...484950...432 Σελίδα 49 από 432

MOST POPULAR

Breaking News: Medical Debt and Your Credit Report

23 Μαρτίου, 2022

Axicabtagene Ciloleucel Results in High Response Rates and Durable Remissions as...

5 Οκτωβρίου, 2023

Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers

24 Απριλίου, 2024

Neoadjuvant Pembrolizumab Associated with Limited Side Effects and High Clinical Activity...

16 Ιανουαρίου, 2023

Φόρτωση περισσοτέρων

Better EFS Outcomes with Perioperative Durvalumab Plus FLOT Than with Placebo...

Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC

FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma

ESMO Gynaecological Cancers Congress 2025, Vienna, Austria, 19-21 June

EMA Recommends Granting a Conditional Marketing Authorisation for Zanidatamab

Vepdegestrant Results in Longer PFS Than Fulvestrant in Previously Treated Patients...

Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and...

Similar Median OS Between Ripretinib versus Sunitinib in Patients with Advanced...

FDA Grants Accelerated Approval to the Combination of Avutometinib and Defactinib...

EMA Adopts a Positive Opinion for Biosimilar Denosumab

MOST POPULAR

Breaking News: Medical Debt and Your Credit Report

Axicabtagene Ciloleucel Results in High Response Rates and Durable Remissions as...

Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers

Neoadjuvant Pembrolizumab Associated with Limited Side Effects and High Clinical Activity...

HOT NEWS

El cáncer en mi comunidad: Cómo superar las desigualdades en la...

Tucatinib and Trastuzumab Combination Approved for Advanced Colorectal Cancer

COVID-19, Cancer, and Uncertainty: An Oncologist’s Perspective on Coping

InflaMix Identifies CAR-T Recipients with a Preinfusion Inflammatory Profile Indicative of...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ